Company / Operating Margin
Kymera Therapeutics, Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-891.1%
FY2025
5-year range
-1438.5% / -210.6%
FY2021-FY2025
Trend
-60.3%
vs FY2024
Sector context
#118 of 135
Health Care
What the data says
Kymera Therapeutics, Inc.'s operating margin of -891.1% is lower than 87% of companies in the Health Care sector (FY2025). Declined from -210.6% to -891.1% over the past 2 years.
Based on SEC 10-K filings.
-891.1% in FY2025 with a 5-year CAGR of +547.4%.
Declined from -210.6% to -891.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -546.7pp
- 5-Year Change
- +547.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 135This company -891.1% Sector average -774.4%
▼
-15.1% below sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 60.3% year-over-year.
- Currently 116.6pp below the Health Care sector average.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -891.1% | -60.3% |
| FY2024 | -555.8% | -163.9% |
| FY2023 | -210.6% | +38.8% |
| FY2022 | -344.4% | +76.1% |
| FY2021 | -1438.5% | +0.0% |
| FY2020 | -1438.5% | - |
| FY2019 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026